Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
breast cancer
Mar 25, 2024, 07:01 |
Opinion
Francisco J. Esteva: It is important to understand the treatment of early breast cancer must be individualized
Francisco J. Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill…
Mar 23, 2024, 23:31 |
Blog
Antonio Marra: Our review on current use and future development of PARP inhibitors in breast cancer just out in JAMA Oncology
Antonio Marra, Medical Oncologist at the European Institute of Oncology, on LinkedIn: “Excited to see…
Mar 23, 2024, 23:01 |
Blog
Maryam Lustberg: In honor of PCDI’s founder Anne Loeser this piece stands as a heartfelt tribute to her legacy following her passing on October 10, 2023 from metastatic breast cancer
Mar 23, 2024, 15:49 |
Blog
Mohammed Ibrahim: Honoring the Strength of Breast Cancer Survivors
Mohammed Ibrahim, Head of Oncology Unit at Saint Paul's Hospital Millennium Medical College, posted on…
Mar 23, 2024, 14:29 |
Insight
Jennifer Douglas: A Breast Cancer Journey: Living it One Step at a Time
Jennifer Douglas, Writer and DCIS Breast Cancer Patient Advocate, shared on LinkedIn: "It was startling…
Mar 23, 2024, 04:35 |
Insight
Piotr Wysocki: How can we optimize the endocrine treatment of advanced HR+/HER2- breast cancer?
Piotr Wysocki, Professor of Medicine, Head of Department of Oncology at Jagiellonian University Hospital, recently…
Mar 22, 2024, 23:32 |
Insight
Piotr J. Wysocki: Ribociclib combined with an aromatase inhibitor in the adjuvant treatment of breast cancer – interim analysis of Natalee study
Piotr J. Wysocki, Head of the Oncology Department at the University Hospital Krakow, shared a post…
Mar 22, 2024, 15:23 |
Blog
Piotr J. Wysocki: Regular, personalized follow-up in breast cancer survivors may not improve long-term outcomes but significantly improves patients’ quality of life
Piotr J. Wysocki, Head of the Oncology Department at the University Hospital Krakow, shared a…
Mar 21, 2024, 10:46 |
Insight
Adding ribociclib to hormone therapy reduces the risk of breast cancer recurrence - UCLA Health
Drug regimen significantly improves invasive disease-free survival for patients with stage 2 or 3 HR-positive,…
Mar 18, 2024, 19:11 |
Blog
Fredrick Chite Asirwa: International Cancer Institute clinic is recruiting breast cancer patients for clinical trials currently
Fredrick Chite Asirwa, CEO/Executive Director of International Cancer Institute, posted on LinkedIn: "To contribute to…
48
49
50
51
52
All:
2595
Posts:
491 - 500
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Vivek Subbiah: Key publications leading to Nobel Prize 2024, published in 1993
Dr. Zainab Shinkafi-Bagudu: Advocating for Equity in Cancer Care - UICC Presidential Candidacy
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
ASTRO24: 15 Posts Not To Miss From Day 4
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube